Stephen Malin

Dr. Stephen Malin


Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 May 2022 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
ACApril S. Caravaca
April S. Caravaca
AGAlessandro L. Gallina
Alessandro L. Gallina
LTLaura Tarnawski
Laura Tarnawski
VSVladimir S. Shavva
Vladimir S. Shavva
RCRomain A. Colas
Romain A. Colas
POPeder S. Olofsson
Peder S. Olofsson
Significance: Resolution of inflammation is an active process that restores tissue homeostasis and prevents the development of chronic inflammatory diseases. The mechanisms that regulate resolution of inflammation are only partially understood. Here, we showed that activation of the vagus nerve accelerated resolution of inflammation. Electrical stimulation of the vagus nerve in vivo increased levels of select specialized proresolving mediators in inflammation. Experiments in genetic mouse models revealed that the mechanism involved 12/15-lipoxgenase (Alox15), a key enzyme for biosynthesis of the identified mediators, and required the α7-nicotinic acetylcholine receptor subunit. The findings indicate that electrical signals in the vagus nerve activate a cholinergic signal promoting Alox15-dependent lipid mediator biosynthesis and accelerating resolution of inflammation, providing additional insights into neural regulation of inflammation.

29 July 2021 in Science Immunology
Verified
Journal Article
Closed access
LCLesly Calderón
Lesly Calderón
KSKarina Schindler
Karina Schindler
SMStephen Malin
Stephen Malin
ASAlexandra Schebesta
Alexandra Schebesta
QSQiong Sun
Qiong Sun
MBMeinrad Busslinger
Meinrad Busslinger
Pax5 controls the generation, proliferation, and survival of all mature B cells by promoting PI3K signaling via PTEN down-regulation.

1 August 2018 in Arteriosclerosis, Thrombosis, and Vascular Biology
Verified
Journal Article
Closed access
PDF file
MCMonica Centa
Monica Centa
KPKajsa E. Prokopec
Kajsa E. Prokopec
MGManasa G. Garimella
Manasa G. Garimella
KHKatrin Habir
Katrin Habir
LHLisa Hofste
Lisa Hofste
SMStephen Malin
Stephen Malin
Objective—: Dyslipidemia is a component of the metabolic syndrome, an established risk factor for atherosclerotic cardiovascular disease, and is also observed in various autoimmune and chronic inflammatory conditions. However, there are limited opportunities to study the impact of acquired dyslipidemia on cardiovascular and immune pathology. Approach and Results—: We designed a model system that allows for the conversion to a state of acute hyperlipidemia in adult life, so that the consequences of such a transition could be observed, through conditionally deleting APOE (apolipoprotein E) in the adult mouse. The transition to hypercholesterolemia was accompanied by adaptive immune responses, including the expansion of T lymphocyte helper cell 1, T follicular helper cell, and T regulatory subsets and the formation of germinal centers. Unlike steady-state Apoe −/− mice, abrupt loss of APOE induced rapid production of antibodies recognizing rheumatoid disease autoantigens. Genetic ablation of the germinal center reduced both autoimmunity and atherosclerosis, indicating that the immune response that follows loss of APOE is independent of atherosclerosis but nevertheless promotes plaque development. Conclusions—: Our findings suggest that immune activation in response to hyperlipidemia could contribute to a wide range of inflammatory autoimmune diseases, including atherosclerosis.

29 March 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
LTLaura Tarnawski
Laura Tarnawski
VSVladimir S. Shavva
Vladimir S. Shavva
EKEric J. Kort
Eric J. Kort
ZZZhengbing Zhuge
Zhengbing Zhuge
INIngrid Nilsson
Ingrid Nilsson
POPeder S. Olofsson
Peder S. Olofsson
Endothelial dysfunction and impaired vasodilation are linked with adverse cardiovascular events. T lymphocytes expressing choline acetyltransferase (ChAT), the enzyme catalyzing biosynthesis of the vasorelaxant acetylcholine (ACh), regulate vasodilation and are integral to the cholinergic antiinflammatory pathway in an inflammatory reflex in mice. Here, we found that human T cell ChAT mRNA expression was induced by T cell activation involving the PI3K signaling cascade. Mechanistically, we identified that ChAT mRNA expression was induced following the attenuation of RE-1 Silencing Transcription factor REST-mediated methylation of the ChAT promoter, and that ChAT mRNA expression levels were up-regulated by GATA3 in human T cells. In functional experiments, T cell-derived ACh increased endothelial nitric oxide-synthase activity, promoted vasorelaxation, and reduced vascular endothelial activation and promoted barrier integrity by a cholinergic mechanism. Further, we observed that survival in a cohort of patients with severe circulatory failure correlated with their relative frequency of ChAT  + CD4 + T cells in blood. These findings on ChAT + human T cells provide a mechanism for cholinergic immune regulation of vascular endothelial function in human inflammation.

22 January 2018 in Arthritis & Rheumatology
Verified
Journal Article
Closed access
PDF file
ADAlbert Dahdah
Albert Dahdah
KHKatrin Habir
Katrin Habir
Kutty Selva NandakumarKutty Selva Nandakumar
Kutty Selva Nandakumar
ASAmit Saxena
Amit Saxena
BXBingze Xu
Bingze Xu
SMStephen Malin
Stephen Malin

11 August 2020 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
GLGrace J. Liu
Grace J. Liu
MJMarkus Jaritz
Markus Jaritz
MWMiriam Wöhner
Miriam Wöhner
BABenedikt Agerer
Benedikt Agerer
ABAndreas Bergthaler
Andreas Bergthaler
MBMeinrad Busslinger
Meinrad Busslinger
B cell and plasma cell fates are controlled by different transcriptional networks, as exemplified by the mutually exclusive expression and cross-antagonism of the B cell identity factor Pax5 and the plasma cell regulator Blimp1. It has been postulated that repression of Pax5 by Blimp1 is essential for plasma cell development. Here, we challenged this hypothesis by analyzing the IghPax5/+ mouse, which expressed a Pax5 minigene from the immunoglobulin heavy-chain locus. Despite high Pax5 expression, plasma cells efficiently developed in young IghPax5/+ mice at steady state and upon immunization, while their number moderately declined in older mice. Although Pax5 significantly deregulated the plasma cell expression program, key plasma cell regulators were normally expressed in IghPax5/+ plasma cells. While IgM and IgA secretion by IghPax5/+ plasma cells was normal, IgG secretion was modestly decreased. Hence, Pax5 repression is not essential for robust plasma cell development and antibody secretion, although it is required for optimal IgG production and accumulation of long-lived plasma cells.